Opportunity Information: Apply for RFA GH 11 004
Apply for RFA GH 11 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Research Activities In Support Of Malaria Prevention and Control in the Republic Of Uganda As Part of the President s Malaria Initiative" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 13, 2010 and posted on Dec 13, 2010.
- Applicants must submit their applications by Feb 16, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Independent school districts Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) County governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Private institutions of higher education For profit organizations other than small businesses.
- Eligible organizations include Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) For Profit Organizations Small Businesses For Profit Organizations (Other than Small Businesses) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American tribal organizations (other than Federally recognized tribal governments) Faith based or Community based Organizations Regional Organizations Non domestic (non U.S.) Entities (Foreign Organizations) Bona Fide Agents A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Non domestic (non U.S.) entities are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, issued by the Centers for Disease Control and Prevention (CDC) under the President's Malaria Initiative (PMI), is focused on supporting research and evaluation work that strengthens malaria prevention and control in the Republic of Uganda. The underlying idea is to fund practical, high-impact public health projects that can generate actionable evidence, improve program performance, and ultimately reduce malaria illness and death. The opportunity is also tied to CDC's role in the Roll Back Malaria (RBM) partnership, a global effort aimed at coordinating malaria scale-up, measuring results, and accelerating progress toward malaria control targets. In Uganda specifically, CDC is looking to expand its collaboration network and support research that directly informs malaria policy and operations.
The program has three main goals. First, it aims to conduct operational research as well as monitoring and evaluation activities in Uganda, working alongside the national malaria program and other in-country partners. This means the work is intended to be grounded in real program conditions, such as how malaria interventions are delivered, who is reached, how consistently services are provided, and what barriers prevent effective coverage. Second, the grant is intended to help develop, test, and validate the impact of revised, improved, or entirely new malaria interventions that could strengthen control efforts. In practice, this could include refinements to existing prevention or treatment strategies, improved implementation approaches, or new tools and methods that can be shown to make a measurable difference. Third, the opportunity emphasizes translating research results into public health practice by supporting the Ministry of Health in applying findings to policy, guidelines, and program decisions. It also stresses the importance of sharing expertise and lessons learned with other malaria partners and potentially other countries, so that evidence generated in Uganda can contribute to broader regional or global learning.
Administratively, this funding was offered as a discretionary cooperative agreement, which typically indicates substantial involvement and collaboration with CDC during the project period rather than a hands-off grant. The funding opportunity number is RFA-GH-11-004, and it falls under the health category with CFDA number 93.283 (CDC Investigations and Technical Assistance). CDC anticipated making one award, with an estimated total funding amount of $1,500,000. The listed award ceiling is $300,000, with no stated award floor. There is no cost sharing or matching requirement, which can reduce financial barriers for applicants and allow proposals to focus resources on technical and operational priorities.
Eligibility is broad across many types of U.S.-based entities, including public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), state and local governments, tribal governments and organizations, special district governments, independent school districts, public housing authorities, faith-based and community-based organizations, small businesses, and other for-profit organizations. The announcement also notes the possibility of applying as a bona fide agent of a state or local government, but that route requires a formal legal agreement documenting that status. A critical restriction is that non-U.S. (foreign) organizations are not eligible to apply, and foreign components of U.S. organizations are not allowed, meaning the applicant organization must be domestic and structured in a way that complies with these limits even if the work itself is conducted in Uganda.
In terms of timing, the opportunity was posted on December 13, 2010, with a closing date of February 16, 2011, and it was archived on February 17, 2011. For support in accessing the full announcement, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) via the provided phone number. Overall, the opportunity is best understood as a targeted investment in Uganda-focused malaria operational research and evaluation that is designed not just to produce reports, but to directly influence malaria programming, strengthen national decision-making, and contribute evidence that can be shared across the broader malaria control community.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This CDC funding opportunity under the President's Malaria Initiative (PMI) supports research, operational research, and monitoring and evaluation activities that strengthen malaria prevention and control in the Republic of Uganda. The emphasis is on practical, high-impact public health work that generates actionable evidence to improve program performance and reduce malaria illness and death.
Which agency is offering the funding?
The opportunity is issued by the Centers for Disease Control and Prevention (CDC) under PMI, and it aligns with CDC's work within the Roll Back Malaria (RBM) partnership.
What is the funding opportunity number?
The funding opportunity number is RFA-GH-11-004.
What CFDA program is this associated with?
The CFDA number listed for this opportunity is 93.283 (CDC Investigations and Technical Assistance).
What type of award is this?
The award is a discretionary cooperative agreement. This typically means CDC expects substantial involvement and collaboration with the award recipient during the project period rather than operating as a hands-off grant.
How many awards did CDC anticipate making?
CDC anticipated making one award.
How much total funding was estimated for this opportunity?
The estimated total funding amount listed is $1,500,000.
What is the award ceiling?
The listed award ceiling is $300,000.
Is there an award floor (minimum award amount)?
No award floor is stated in the provided information.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
What are the main program goals?
The opportunity describes three main goals: (1) conduct operational research and monitoring and evaluation activities in Uganda in partnership with the national malaria program and other in-country partners; (2) develop, test, and validate revised, improved, or new malaria interventions to strengthen control efforts; and (3) translate research results into public health practice by supporting the Ministry of Health to apply findings to policy, guidelines, and program decisions, while sharing lessons learned with other partners and potentially other countries.
What kinds of activities are encouraged under the first goal (operational research and M&E)?
The work is intended to be grounded in real program conditions, such as evaluating how malaria interventions are delivered, who is reached, how consistently services are provided, and what barriers prevent effective coverage. Activities can include operational research as well as monitoring and evaluation in collaboration with Uganda's national malaria program and in-country partners.
What does the opportunity mean by developing or validating malaria interventions?
It emphasizes developing, testing, and validating the impact of revised, improved, or entirely new interventions that could strengthen malaria control. The description includes refinements to existing prevention or treatment strategies, improved implementation approaches, or new tools and methods that can demonstrate measurable impact.
How is CDC expecting research results to be used?
The opportunity stresses translation of research into practice by supporting Uganda's Ministry of Health in applying findings to policy, guidelines, and program decisions. It also highlights sharing expertise and lessons learned with other malaria partners and potentially other countries.
How does this opportunity relate to the Roll Back Malaria (RBM) partnership?
The opportunity is tied to CDC's role in the RBM partnership, described as a global effort to coordinate malaria scale-up, measure results, and accelerate progress toward malaria control targets. Evidence generated in Uganda is positioned to contribute to broader learning within that community.
Where is the work expected to focus geographically?
The focus is explicitly on supporting malaria prevention and control work in the Republic of Uganda.
Who is eligible to apply?
Eligibility is broad for U.S.-based entities, including: public and private institutions of higher education; nonprofits (with or without 501(c)(3) status); state and local governments; tribal governments and organizations; special district governments; independent school districts; public housing authorities; faith-based and community-based organizations; small businesses; and other for-profit organizations.
Can a for-profit organization apply?
Yes. The eligibility list includes small businesses and other for-profit organizations.
Can a nonprofit without 501(c)(3) status apply?
Yes. The eligibility description includes nonprofits with and without 501(c)(3) status.
Can a non-U.S. (foreign) organization apply?
No. Non-U.S. (foreign) organizations are not eligible to apply.
Are foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations are not allowed, meaning the applicant must be domestic and structured to comply with these limits even if the work itself is conducted in Uganda.
What does it mean to apply as a bona fide agent of a state or local government?
The announcement notes that an organization may apply as a bona fide agent of a state or local government, but doing so requires a formal legal agreement documenting that status.
When was the opportunity posted and when did it close?
It was posted on December 13, 2010. The closing date was February 16, 2011.
Is this opportunity still open?
No. The opportunity was archived on February 17, 2011.
What is the overall purpose or intended impact in Uganda?
The opportunity is described as a targeted investment in Uganda-focused malaria operational research and evaluation designed not just to produce reports, but to influence malaria programming, strengthen national decision-making, and generate evidence that can be shared across the broader malaria control community.
How could applicants get help accessing the full announcement (as described in the notice)?
CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) via the provided phone number for support in accessing the full announcement.
Browse more opportunities from the same category: Health
Next opportunity: Title XVI Water Reclamation and Reuse Program Construction Activities for Fiscal Year 2011
Previous opportunity: Informatics Tools for High Throughput Sequence Data Analysis (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH 11 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH 11 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pilot for State specific Cross Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes Apply for RFA DD 11 004 Funding Number: RFA DD 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Mendelian Disorders Genome Centers (U54) Apply for RFA HG 10 016 Funding Number: RFA HG 10 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genome Sequencing and Analysis Centers (U54) Apply for RFA HG 10 015 Funding Number: RFA HG 10 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Muscular Dystrophy Surveillance Tracking and Research Network MD STARnet Feasibility of Expansion to other Muscular Dystrophies Apply for RFA DD 11 006 Funding Number: RFA DD 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Limited Competition for the Renewal of the National Cell Repository for Alzheimers Disease (NCRAD) (U24) Apply for PAR 11 080 Funding Number: PAR 11 080 Agency: National Institutes of Health Category: Health Funding Amount: $675,000 |
| Expanding Maternal and Neonatal Survival (EMAS) Apply for RFA 497 11 000002 Funding Number: RFA 497 11 000002 Agency: Indonesia USAID Jakarta Category: Health Funding Amount: $55,000,000 |
| HIV Prevention with Youth and Adults Program in Lesotho Apply for 674 11 0004 Funding Number: 674 11 0004 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $17,000,000 |
| Clinical Sequencing Exploratory Research (U01) Apply for RFA HG 10 017 Funding Number: RFA HG 10 017 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Development of a Preliminary Evidence Base to Inform Decision making about Returning Research Results to Participants in Genomic Studies (R01) Apply for RFA HG 11 003 Funding Number: RFA HG 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Ethical, Legal, and Social Implications of Returning Research Results to Genomic Research Participants (R21) Apply for RFA HG 11 004 Funding Number: RFA HG 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Long Term MCH Training LEND Apply for HRSA 11 036 Funding Number: HRSA 11 036 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Disparities in Perinatal Health Border, Alaska and Hawaii Apply for HRSA 11 018 Funding Number: HRSA 11 018 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Improving Access to Hearing Health Care (STTR) R41/R42 Apply for RFA DC 12 002 Funding Number: RFA DC 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Access to Hearing Health Care (SBIR) R43/R44 Apply for RFA DC 12 001 Funding Number: RFA DC 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease Apply for RFA CK 11 005 Funding Number: RFA CK 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Combining Subjective and Objective Methods for Quantifying Contact Rates and Mixing Pattern in School Aged Children Apply for RFA CK 11 006 Funding Number: RFA CK 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Apply for PAR 11 083 Funding Number: PAR 11 083 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) Apply for PAR 11 082 Funding Number: PAR 11 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Spina Bifida Registry Longitudinal Data Collection and Evaluation (U01) Apply for RFA DD 11 005 Funding Number: RFA DD 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| NIAID Science Education Awards (R25) Apply for PAR 11 086 Funding Number: PAR 11 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 11 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.